StockTok Wire

StockTok’s daily headlines and financial news driving the broader market

Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate

NEWTON, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced the initiation of two Phase 2, single-arm investigator-sponsored trials evaluating ACER-801 (osanetant) in men with adenocarcinoma of

Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate Read More »

Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care By Investing.com

ROANOKE, Va. and FRANKLIN LAKES, N.J., Jan. 22, 2025 /PRNewswire/ — Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Carilion is the first health system in the state and

Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care By Investing.com Read More »

Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences

WARREN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that it has entered into a license agreement for the development and commercialization of INOpulse® with Baylor BioSciences, a life sciences company dedicated to the

Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences Read More »

Prince Harry wins apology from Rupert Murdoch’s UK papers By Reuters

LONDON (Reuters) – Prince Harry settled his lawsuit against Rupert Murdoch’s News Group Newspapers (NGN) over alleged unlawful information gathering, his lawyer said on Wednesday. Harry’s lawyer said a deal had been struck after NGN agreed to pay significant damages and admitted Harry, younger son of Britain’s King Charles, had been the victim of unlawful

Prince Harry wins apology from Rupert Murdoch’s UK papers By Reuters Read More »

Norway’s wealth fund acquires stake in London’s Mayfair properties for $378 million By Investing.com

Investing.com — Norway’s sovereign wealth fund, managed by Norges Bank Investment Management, has purchased a 25% stake in a portfolio of office and retail properties in London’s upscale Mayfair district. The transaction was valued at approximately £306 million ($378 million). The portfolio includes about 175 buildings situated around Grosvenor Street and Mount Street. The acquisition

Norway’s wealth fund acquires stake in London’s Mayfair properties for $378 million By Investing.com Read More »